New technologies such as single-cell sequencing, single molecule real time sequencing (SMRT) and CRISPR/Cas9 can be used to study the role of epigenetics in CD8+ T cells in the pathogenesis of autoimmune diseases, and may result in the discovery of novel biomarkers for diagnosis, disease monitoring, and therapeutic validation. This evidence concerns the gene CD8A and autoimmune disease.